About Alexis Borisy
Alexis Borisy is a director at Prana Therapies.
Alexis Borisy reports to the SEC as a director or officer of 11 public companies, including Revolution Medicines (RVMD), Parabilis Medicines (PBLS) and Relay Therapeutics (RLAY).
Alexis Borisy appears on fund filings for Curie Bio Seed.
Alexis Borisy first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Alexis Borisy in the role, so the role may have started earlier or lasted longer.
Prana Therapies, Inc.
Director
2026 · Encinitas, CA
Develops antibody medicines for people with respiratory and skin diseases.
RI
Revolution Medicines, Inc.
Director
2020 – 2026 · Public company (RVMD)
PI
Parabilis Medicines, Inc.
Director
2026 · Public company (PBLS)
RI
Relay Therapeutics, Inc.
Director
2020 – 2026 · Public company (RLAY)
BC
Blueprint Medicines Corp
Director
2015 – 2025 · Public company (BPMC)
TI
Tango Therapeutics, Inc.
Director
2021 – 2025 · Public company (TNGX)
CS
EI
EQRx, Inc.
Executive Chairman
2021 – 2023 · Public company (EQRX)
OI
Opko Health, Inc.
Director
2022 – 2023 · Public company (OPK)
DI
Dianthus Therapeutics, Inc.
Director
2018 – 2021 · Public company (DNTH)
FI
Foundation Medicine, Inc.
Director
2013 – 2018 · Public company (FMI)
EI
Editas Medicine, Inc.
Director
2016 – 2017 · Public company (EDIT)
EI
EPIRUS Biopharmaceuticals, Inc.
CEO & President, director
2006 – 2009 · Public company (EPRS)
Key Colleagues at Startups
The people Alexis Borisy works with at each company, as listed on that company's latest Form D.
Prana Therapies, Inc. · Form D, Aug 10, 2026
BA
Ben Auspitz
Director
SD
Sheila Gujrathi, M.D.
Chief Executive Officer and director
Hector Ortega
Chief Medical Officer
Ryan Sullivan
Chief Scientific Officer